N. prodotti: 0
Totale ordine: € 0,00
Indexed/Abstracted in: Chemical Abstracts, CINAHL, Current Contents/Clinical Medicine, EMBASE, PubMed/MEDLINE, Science Citation Index Expanded (SciSearch), Scopus
Impact Factor 1,111
Online ISSN 1827-1928
Muntaner-Mas A. 1, Vidal-Conti J. 1, Borràs P. A. 1, Ortega F. B. 2, Palou P. 1
1 Physical Activity and Sport Science Research Group (GICAFE), Department of Physical Education and Sports, Faculty of Education, University of the Balearic Islands, Majorca, Spain;
2 PROmotingFITness and Health through physical activity research group (PROFITH), Department of Physical Education and Sports, Faculty of Sport Sciences, University of Granada, Spain
AIM: This pilot study evaluated the feasibility and preliminary effectiveness of a 10-week WhatsApp-based intervention aimed at enhancing health-related physical fitness components and cardiovascular disease (CVD) risk factors compared with a face-to-face condition.
METHODS: Participants (n= 32) were assigned to one of three groups: Training group (n= 16), Mobile group (n= 7) and Control group (n= 9). Training group and Mobile group performed the same training program, based on strength training with elastics bands and aerobic exercise, during 10 weeks; only the delivery mode differed.
RESULTS: The Mobile group increased handgrip strength, aerobic capacity and decreased systolic blood pressure and heart rate after exercise though there were no significant differences respect to Control group. The Training group decreased significantly systolic blood pressure (P = 0.038), diastolic blood pressure (P = 0.005), mean arterial pressure (P = 0.006) and heart rate after exercise (P = 0.002), respect to Control group.
CONCLUSION: Comparison between Training and Mobile group showed that WhatsApp-based physical activity intervention was less effective than face-to-face condition. The results indicate that the use of an online social network (WhatsApp) produced slight changes in some health-related physical fitness components and CVD risk factors. ClinicalTrials.gov: NCT02327975